About us
Bringing lab science into the clinic.
TovCell Bio was founded in 2026 in Incheon, South Korea, near Seoul, to bring mitochondria science into clinics and future therapies. We are a member of The Tov House.
- PurposeRestoring the good within us
- VisionTo become the global standard for restoring cellular energy
- MissionLab science — into clinic procedures today, therapies tomorrow
means “good” in Hebrew. TovCell joins Tov (good) and Cell — a name for restoring the good energy of every cell.
Our Leadership
The team.
The leadership driving TovCell Bio’s vision and innovation.
Jewoong Ko
Co-CEOFormer CEO, LANXESS Korea · Former Senior Vice President, Bayer Korea

Euna Park
Co-CEOOwner, Athena · M.S. Biotechnology

Yongsu Choi
CTOProfessor, Department of Advanced Biopharmaceutical Sciences, Inha University

Paul Cho
CGOOwner, KhaiEL Group

Mina Lim
Senior ManagerMitochondria isolation & preservation research · first inventor of a preservation patent

Eunseo Baek
Assistant ManagerLarge-scale mitochondria isolation process · M.S. Life Science

One group,
two companies, two roles.
Ingredients — plant-derived mitochondria (MitoZai™)
Medicine — a mitochondria-based clinic platform and therapies
Where we are.
Room 601, Building 1, Inha Dream Center
100 Inha-ro, Michuhol-gu, Incheon 22212
AthenaTov OÜ
Tornimäe tn 5, 10145 Tallinn, Estonia
tov@athenatov.com
www.athenatov.com